ASO Author Reflections: Does Elevation of the Prognostic Factor Plasma Fibrinogen Level Reflect the Tumor Microenvironment at the Primary Site?

Shota Hoshino; Satoru Matsuda; Hirofumi Kawakubo; Shigeo Yamaguchi; Kohei Nakamura; Eriko Aimono; Kazuaki Matsui; Tomoyuki Irino; Kazumasa Fukuda; Rieko Nakamura; Hajime Okita; Hiroshi Nishihara; Hiroya Takeuchi; Yuko Kitagawa

doi:10.1245/s10434-022-12040-y

ASO Author Reflections: Does Elevation of the Prognostic Factor Plasma Fibrinogen Level Reflect the Tumor Microenvironment at the Primary Site?

Shota Hoshino, Satoru Matsuda, Hirofumi Kawakubo, Shigeo Yamaguchi, Kohei Nakamura, Eriko Aimono, Kazuaki Matsui, Tomoyuki Irino, Kazumasa Fukuda, Rieko Nakamura, Hajime Okita, Hiroshi Nishihara, Hiroya Takeuchi, Yuko Kitagawa

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	6905-6906
Number of pages	2
Journal	Annals of Surgical Oncology
Volume	29
Issue number	11
DOIs	https://doi.org/10.1245/s10434-022-12040-y
Publication status	Published - 2022 Oct

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1245/s10434-022-12040-y

Cite this

Hoshino, S., Matsuda, S., Kawakubo, H., Yamaguchi, S., Nakamura, K., Aimono, E., Matsui, K., Irino, T., Fukuda, K., Nakamura, R., Okita, H., Nishihara, H., Takeuchi, H., & Kitagawa, Y. (2022). ASO Author Reflections: Does Elevation of the Prognostic Factor Plasma Fibrinogen Level Reflect the Tumor Microenvironment at the Primary Site? Annals of Surgical Oncology, 29(11), 6905-6906. https://doi.org/10.1245/s10434-022-12040-y

Hoshino, S, Matsuda, S , Kawakubo, H, Yamaguchi, S, Nakamura, K, Aimono, E, Matsui, K, Irino, T, Fukuda, K , Nakamura, R , Okita, H , Nishihara, H, Takeuchi, H & Kitagawa, Y 2022, 'ASO Author Reflections: Does Elevation of the Prognostic Factor Plasma Fibrinogen Level Reflect the Tumor Microenvironment at the Primary Site?', Annals of Surgical Oncology, vol. 29, no. 11, pp. 6905-6906. https://doi.org/10.1245/s10434-022-12040-y

@article{64f7364129b64558973e0150d7a95f1f,

title = "ASO Author Reflections: Does Elevation of the Prognostic Factor Plasma Fibrinogen Level Reflect the Tumor Microenvironment at the Primary Site?",

author = "Shota Hoshino and Satoru Matsuda and Hirofumi Kawakubo and Shigeo Yamaguchi and Kohei Nakamura and Eriko Aimono and Kazuaki Matsui and Tomoyuki Irino and Kazumasa Fukuda and Rieko Nakamura and Hajime Okita and Hiroshi Nishihara and Hiroya Takeuchi and Yuko Kitagawa",

note = "Funding Information: Yuko Kitagawa received lecture fees from Chugai Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd, Asahi Kasei Pharma Corporation, Otsuka Pharmaceutical Factory, Inc., Shionogi & Co., Ltd., Nippon Covidien, Inc., Ono Pharmaceutical Co., Ltd., and Bristol-Myers Squibb K.K, and was supported by grants from Chugai Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd, Yakult Honsha Co., Ltd., AsahiKasei Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Tsumura & Co., Kyouwa Hakkou Kirin Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., EA Pharma Co., Ltd., Astellas Pharma, Inc., Toyama Chemical Co., Ltd., Medicon, Inc., Kaken Pharmaceutical Co. Ltd., Eisai Co., Ltd., Otsuka Pharmaceutical Factory, Inc., Teijin Pharma, Ltd., Nihon Pharmaceutical Co., Ltd., and Nippon Covidien Inc. Yuko Kitagawa held an endowed chair provided by Chugai Pharmaceutical Co., Ltd. and Taiho Pharmaceutical Co., Ltd, outside the submitted work. The remaining authors have no conflicts of interest. ",

year = "2022",

month = oct,

doi = "10.1245/s10434-022-12040-y",

language = "English",

volume = "29",

pages = "6905--6906",

journal = "Annals of Surgical Oncology",

issn = "1068-9265",

publisher = "Springer New York",

number = "11",

}

TY - JOUR

T1 - ASO Author Reflections

T2 - Does Elevation of the Prognostic Factor Plasma Fibrinogen Level Reflect the Tumor Microenvironment at the Primary Site?

AU - Hoshino, Shota

AU - Matsuda, Satoru

AU - Kawakubo, Hirofumi

AU - Yamaguchi, Shigeo

AU - Nakamura, Kohei

AU - Aimono, Eriko

AU - Matsui, Kazuaki

AU - Irino, Tomoyuki

AU - Fukuda, Kazumasa

AU - Nakamura, Rieko

AU - Okita, Hajime

AU - Nishihara, Hiroshi

AU - Takeuchi, Hiroya

AU - Kitagawa, Yuko

N1 - Funding Information: Yuko Kitagawa received lecture fees from Chugai Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd, Asahi Kasei Pharma Corporation, Otsuka Pharmaceutical Factory, Inc., Shionogi & Co., Ltd., Nippon Covidien, Inc., Ono Pharmaceutical Co., Ltd., and Bristol-Myers Squibb K.K, and was supported by grants from Chugai Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd, Yakult Honsha Co., Ltd., AsahiKasei Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Tsumura & Co., Kyouwa Hakkou Kirin Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., EA Pharma Co., Ltd., Astellas Pharma, Inc., Toyama Chemical Co., Ltd., Medicon, Inc., Kaken Pharmaceutical Co. Ltd., Eisai Co., Ltd., Otsuka Pharmaceutical Factory, Inc., Teijin Pharma, Ltd., Nihon Pharmaceutical Co., Ltd., and Nippon Covidien Inc. Yuko Kitagawa held an endowed chair provided by Chugai Pharmaceutical Co., Ltd. and Taiho Pharmaceutical Co., Ltd, outside the submitted work. The remaining authors have no conflicts of interest.

PY - 2022/10

Y1 - 2022/10

UR - http://www.scopus.com/inward/record.url?scp=85132207971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85132207971&partnerID=8YFLogxK

U2 - 10.1245/s10434-022-12040-y

DO - 10.1245/s10434-022-12040-y

M3 - Article

C2 - 35717519

AN - SCOPUS:85132207971

SN - 1068-9265

VL - 29

SP - 6905

EP - 6906

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

IS - 11

ER -

ASO Author Reflections: Does Elevation of the Prognostic Factor Plasma Fibrinogen Level Reflect the Tumor Microenvironment at the Primary Site?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this